A 28-year-old woman with newly diagnosed pulmonary tuberculosis is started on standard first-line therapy (HRZE). She is also on oral contraceptives for menstrual regulation. After 1 month, she reports breakthrough bleeding and is concerned about contraceptive failure. What is the mechanism of this drug–drug interaction and which anti-TB agent is primarily responsible?